761
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

A population-based study on the incidence and aetiology of infectious complications in peritoneal dialysis in South Sweden

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 230-243 | Received 24 Jul 2023, Accepted 03 Dec 2023, Published online: 15 Dec 2023

References

  • Vos T, Abajobir AA, Abbafati C, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211–1259. doi: 10.1016/S0140-6736(17)32154-2.
  • Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. The Lancet. 2020;395(10225):709–733. doi: 10.1016/S0140-6736(20)30045-3.
  • Cockwell P, Fisher L-A. The global burden of chronic kidney disease. Lancet. 2020;395(10225):662–664. doi: 10.1016/S0140-6736(19)32977-0.
  • Stevens RE, Baskin S, Greene JA, et al. Peritoneal dialysis in the management of chronic renal failure. JAMA. 1964;190(13):1128–1130. doi: 10.1001/jama.1964.03070260040017.
  • Palmer RA. As it was in the beginning: a history of peritoneal dialysis. Perit Dial Int. 1981;2(1):16–22. doi: 10.1177/089686088100200107.
  • Feiman R, Mena Castro E, Gordillo-Paniagua G. [Chronic peritoneal dialysis in childhood]. Bol Med Hosp Infant Mex. 1981;38(3):415–424.
  • Zhang Q, Ren H, Xie J, et al. Causes of death in peritoneal dialysis patients with different kidney diseases and comorbidities: a retrospective clinical analysis in a Chinese center. Int Urol Nephrol. 2014;46(6):1201–1207. doi: 10.1007/s11255-013-0561-5.
  • Chen JHC, Johnson DW, Hawley C, et al. Association between causes of peritoneal dialysis technique failure and all-cause mortality. Sci Rep. 2018; 8(1):3980. doi: 10.1038/s41598-018-22335-4.
  • Boudville N, Kemp A, Clayton P, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol. 2012;23(8):1398–1405. doi: 10.1681/ASN.2011121135.
  • Lloyd A, Tangri N, Shafer LA, et al. The risk of peritonitis after an exit site infection: a time-matched, case-control study. Nephrol Dial Transplant. 2013; 28(7):1915–1921. doi: 10.1093/ndt/gft002.
  • van Diepen AT, Tomlinson GA, Jassal SV. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients. Clin J Am Soc Nephrol. 2012; 7(8):1266–1271. doi: 10.2215/CJN.00980112.
  • Szeto CC, Li PK, Johnson DW, et al. ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int. 2017;37(2):141–154. doi: 10.3747/pdi.2016.00120.
  • Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022; 42(2):110–153. doi: 10.1177/08968608221080586.
  • Wilkie M. The 2016 ISPD update on prevention and treatment of peritonitis-grading the evidence. Perit Dial Int. 2016; 36(5):469–470. doi: 10.3747/pdi.2016.00118.
  • Sahlawi MA, Wilson G, Stallard B, et al. Peritoneal dialysis-associated peritonitis outcomes reported in trials and observational studies: a systematic review. Perit Dial Int. 2020; 40(2):132–140. doi: 10.1177/0896860819893810.
  • Zelenitsky SA, Howarth J, Lagacé-Wiens P, et al. Microbiological trends and antimicrobial resistance in peritoneal dialysis-related peritonitis, 2005 to 2014. Perit Dial Int. 2017;37(2):170–176. doi: 10.3747/pdi.2016.00136.
  • Holley JL, Bernardini J, Piraino B. Risk factors for tunnel infections in continuous peritoneal dialysis. Am J Kidney Dis. 1991; 18(3):344–348. doi: 10.1016/s0272-6386(12)80093-x.
  • Cho Y, Struijk DG. Peritoneal dialysis–related peritonitis: atypical and resistant organisms. Semin Nephrol. 2017; 37(1):66–76. doi: 10.1016/j.semnephrol.2016.10.008.
  • Szeto CC. Peritonitis rates of the past thirty years: from improvement to stagnation. Perit Dial Int. 2014;34(2):151–153. doi: 10.3747/pdi.2014.00007.
  • Szeto CC, Li PK. Peritoneal dialysis-associated peritonitis. Clin J Am Soc Nephrol. 2019;14(7):1100–1105. doi: 10.2215/CJN.14631218.
  • Daly C, Cody JD, Khan I, et al. Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage kidney disease. Cochrane Database Syst Rev. 2014;2014(8):CD003078. doi: 10.1002/14651858.CD003078.pub2.
  • Daly CD, Campbell MK, MacLeod AM, et al. Do the Y‐set and double‐bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant. 2001;16(2):341–347. doi: 10.1093/ndt/16.2.341.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi: 10.1016/0021-9681(87)90171-8.
  • Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481–508. doi: 10.3747/pdi.2016.00078.
  • Marshall MR. A systematic review of peritoneal dialysis-related peritonitis rates over time from national or regional population-based registries and databases. Perit Dial Int. 2021; 42(1):39–47. doi: 10.1177/0896860821996096.
  • Okpechi IG, Ekrikpo U, Moloi MW, et al. Prevalence of peritonitis and mortality in patients with ESKD treated with chronic peritoneal dialysis in Africa: a systematic review. BMJ Open. 2020;10(12):e039970. doi: 10.1136/bmjopen-2020-039970.
  • Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol. 2022; 18(12):779–793. doi: 10.1038/s41581-022-00623-7.
  • Perl J, Fuller DS, Bieber BA, et al. Peritoneal dialysis-related infection rates and outcomes: results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis. 2020;76(1):42–53. doi: 10.1053/j.ajkd.2019.09.016.
  • de la Espada Piña V, Ganga PLQ, Junquero JMG, et al. Two decades of analysis of peritonitis in peritoneal dialysis in andalusia: epidemiological, clinical, microbiological and progression aspects. Nefrologia. 2021;41(4):417–425. doi: 10.1016/j.nefroe.2021.10.004.
  • Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl. 2006;70(103):S55–S62. doi: 10.1038/sj.ki.5001916.
  • Wang HH, Huang CH, Kuo MC, et al. Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: a ten-year single-center study in Taiwan. J Microbiol Immunol Infect. 2019;52(5):752–759. doi: 10.1016/j.jmii.2018.10.013.
  • dos Santos ACML, Hernandes RT, Montelli AC, et al. Clinical and microbiological factors predicting outcomes of nonfermenting gram-negative bacilli peritonitis in peritoneal dialysis. Sci Rep. 2021;11(1):12248. doi: 10.1038/s41598-021-91410-0.
  • Kitterer D, Latus J, Pöhlmann C, et al. Microbiological surveillance of peritoneal dialysis associated peritonitis: antimicrobial susceptibility profiles of a referral center in Germany over 32 years. PLOS One. 2015;10(9):e0135969. doi: 10.1371/journal.pone.0135969.
  • Zeng Y, Jiang L, Lu Y, et al. Peritoneal dialysis-related peritonitis caused by gram-negative organisms: ten-years experience in a single center. Ren Fail. 2021;43(1):993–1003. doi: 10.1080/0886022X.2021.1939050.
  • van Esch S, Krediet RT, Struijk DG. 32 years’ experience of peritoneal dialysis-related peritonitis in a university hospital. Perit Dial Int. 2014; 34(2):162–170. doi: 10.3747/pdi.2013.00275.
  • Zeng Y, Jiang X, Feng S, et al. The influence of seasonal factors on the incidence of peritoneal dialysis-associated peritonitis. Ren Fail. 2020;42(1):807–817. doi: 10.1080/0886022X.2020.1804401.